Medically reviewed by Drugs.com. Last updated on Jul 1, 2019.
Applies to the following strengths: 75 mcg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance
1 inhalation (75 mcg) orally once a day
-This drug should not be used more than one time every 24 hours.
Use: Long term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema
Renal Dose Adjustments
No adjustment is recommended
Liver Dose Adjustments
Mild to moderate liver dysfunction: No adjustment recommended
Severe liver dysfunction: No data available
-Hypersensitivity to any of the ingredients
-Use of a long-acting beta-2 (LABA) agonist without an inhaled corticosteroid (ICS) in asthma patients; this drug is not indicated for asthma treatment
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
-For oral inhalation only.
-Capsules should not be swallowed, it should only be used with the NEOHALER device.
-Administer this drug at the same time of the day.
-The recommended daily dose should not be exceeded.
-Missed dose: The next dose should be taken as soon as it is remembered.
-To ensure proper use of the inhaler device, consult the manufacturer product information.
-Capsules should be stored in the blister, and only removed immediately before use with the inhaler device.
Limitations of use:
-This drug is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease or to treat asthma.
-The safety and effectiveness of this drug in patients with asthma have not been established.
-Patients should read the medication guide and instructions for the use of this drug.
-A rescue inhaler should be provided to patients to treat acute symptoms. Patients should be instructed on how to use the rescue inhaler.
-Notify the physician immediately if experiencing any of the following: Worsening of symptoms; decreasing effectiveness of inhaled, short-acting beta2-agonists; need for more inhalations than usual of the inhaled, short-acting beta2-agonists; significant decrease in lung function.
-Therapy with this drug should not be stopped without physician/provider guidance since symptoms may recur after discontinuation.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about indacaterol
- Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- En Español
- Drug class: adrenergic bronchodilators
Other brands: Arcapta